H.R.4392 - To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.115th Congress (2017-2018)
|Sponsor:||Rep. McKinley, David B. [R-WV-1] (Introduced 11/14/2017)|
|Committees:||House - Energy and Commerce; Ways and Means|
|Latest Action:||House - 11/17/2017 Referred to the Subcommittee on Health. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Related Bills: H.R.4392 — 115th Congress (2017-2018)All Information (Except Text)
A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.